Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SEKISUI Diagnostics Metrix™ COVID-19 Test
The Metrix™ COVID-19 test includes clinical claims for symptomatic and asymptomatic individuals. It allows for an enhanced point-of-care testing experience with dual-sample types for nasal or saliva.
Supplier: SEKISUI Diagnostics MTRXC1925PK
This item is not returnable.
View return policy
Description
- Molecular accuracy without the wait - Improve clinical outcomes by administering immediate treatment in just 30 minutes.
- Accessible molecular testing - Breakthrough platform designed to eliminate cost-barriers.
- Reduce repeat testing - No need for serial or confirmation testing when nasal specimen is used.
- Alleviates testing restrictions - Indicated for symptomatic and asymptomatic testing, allowing for screening prior to medical procedures.
- Simple workflow - Can be performed in any point-of-care setting, with minimal training required.
- Convenient sampling - The only test with dual-sample types, allowing you to provide the best patient experience possible.
- Exceptional Support - Experienced support teams and online training modules to help streamline your testing implementation.
Specifications
| No | |
| COVID-19 | |
| COVID-19 Test | |
| Point-of-Care Testing | |
| Sterile | |
| Liquid Ready-to-Use |
| Waived (FDA, EUA) | |
| No | |
| Reusable | |
| 25 Tests | |
| 30 min. |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction